Crossref
Dual, Postsynaptic 5-HT2B Antagonist and 5-HT1A Agonist Approach to the Treatment of METH/MDMA Addiction and Related Problems. Part 2. Proof of Concept.
Receptors & Clinical Investigation · 2014
DOI: 10.14800/rci.106 ↗Kurz gefasst
Fachartikel in der Zeitschrift Receptors & Clinical Investigation, 2014.
Themen: Sucht und Abhängigkeit
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
(2014). Dual, Postsynaptic 5-HT2B Antagonist and 5-HT1A Agonist Approach to the Treatment of METH/MDMA Addiction and Related Problems. Part 2. Proof of Concept. Receptors & Clinical Investigation. https://doi.org/10.14800/rci.106
Vancouver
Dual, Postsynaptic 5-HT2B Antagonist and 5-HT1A Agonist Approach to the Treatment of METH/MDMA Addiction and Related Problems. Part 2. Proof of Concept. Receptors & Clinical Investigation. 2014. doi:10.14800/rci.106
BibTeX
@article{euvimed2014,
title = {Dual, Postsynaptic 5-HT2B Antagonist and 5-HT1A Agonist Approach to the Treatment of METH/MDMA Addiction and Related Problems. Part 2. Proof of Concept},
journal = {Receptors & Clinical Investigation},
year = {2014},
doi = {10.14800/rci.106}
}
EUVIMED